SOAP Note with CPT and ICD-10 Codes
Subjective
40-year-old female presents for 2-month follow-up of hypertension and weight management. Reports medication non-compliance with current antihypertensive regimen (amlodipine 5 mg daily and losartan-hydrochlorothiazide 100-25 mg daily), stating "I forget." Patient reports current weight management medication (lomira) is ineffective. New complaints include eczematous rash on bilateral upper extremities and bilateral heel pain.
Objective
- Blood pressure: [document actual BP reading]
- Weight: [document actual weight and BMI]
- Skin exam: Eczematous rash noted on bilateral upper extremities
- Musculoskeletal: Bilateral heel tenderness on palpation
Assessment
1. Uncontrolled hypertension with medication non-adherence
- ICD-10: I10 (Essential hypertension)
- ICD-10: Z91.14 (Patient's intentional underdosing of medication regimen due to financial hardship) or Z91.120 (Patient's intentional underdosing of medication regimen for other reason)
2. Overweight/Obesity (document specific BMI)
- ICD-10: E66.9 (Obesity, unspecified) if BMI ≥30
- ICD-10: E66.01 (Morbid obesity due to excess calories) if BMI ≥40 or BMI ≥35 with comorbidity
- ICD-10: Z68.__ (Body mass index [BMI]) - use specific code based on actual BMI
3. Eczematous dermatitis, likely drug-induced
- ICD-10: L30.9 (Dermatitis, unspecified)
- ICD-10: T46.5X5A (Adverse effect of other antihypertensive drugs, initial encounter) - ARBs/ACE inhibitors can cause eczematous reactions 1
4. Bilateral plantar fasciitis
- ICD-10: M72.2 (Plantar fascial fibromatosis)
5. Ineffective weight management pharmacotherapy
- ICD-10: Z79.899 (Other long term [current] drug therapy)
Plan
Hypertension Management
Address medication non-adherence immediately - this is the primary barrier to BP control 2. The 2025 AHA/ACC guidelines emphasize team-based care and addressing barriers to medication adherence 2.
Implement adherence strategies:
- Simplify regimen to once-daily dosing
- Consider pill organizers, smartphone reminders, or medication synchronization
- Assess financial barriers and provide generic alternatives
- Schedule follow-up in 2-4 weeks (not 2 months) for uncontrolled hypertension 2
Medication adjustment: Switch from losartan-hydrochlorothiazide 100-25 mg to losartan-hydrochlorothiazide 50-12.5 mg once daily to reduce pill burden and potentially improve the eczematous rash (lower HCTZ dose may reduce adverse effects) 33. If BP remains uncontrolled after 3 weeks, can uptitrate 33.
Continue amlodipine 5 mg daily - this is appropriate dosing and less likely to cause peripheral edema than higher doses. ARBs like losartan can actually reduce amlodipine-induced edema 4.
Consider adding amlodipine to 10 mg if BP not controlled after addressing adherence, as combination ARB/CCB therapy is highly effective 45.
Eczematous Rash Management
The eczematous rash is likely caused by the ARB (losartan) or ARB-HCTZ combination - this reaction typically develops 4-30 months after initiation and presents as generalized or localized eczema, often on lower extremities but can affect upper extremities 1.
- Trial of topical corticosteroid (triamcinolone 0.1% cream twice daily to affected areas for 2 weeks)
- If rash persists or worsens despite adherence improvement and dose reduction, consider switching from losartan to amlodipine monotherapy or adding a third agent from a different class
- Oral antihistamines are typically ineffective for this drug-induced eczema 1
Weight Management
For BMI ≥27 with hypertension comorbidity or BMI ≥30, pharmacotherapy is indicated as adjunct to lifestyle modification 6.
- Discontinue current ineffective weight management medication (lomira)
- Initiate FDA-approved weight loss medication (specific agent based on contraindications, cost, and patient preference) 6
- Reassess efficacy at 3 months - if <5% weight loss, discontinue and try alternative agent 6
- Reinforce diet, exercise, and behavioral modification as foundation 6
Bilateral Heel Pain
- Conservative management: NSAIDs, heel cushions, stretching exercises, night splints
- Physical therapy referral if no improvement in 4-6 weeks
- Consider orthotic evaluation
Follow-up
- Return in 2-4 weeks for BP recheck and medication adherence assessment (not 2 months - uncontrolled hypertension requires closer monitoring) 2
- Dermatology referral if rash persists despite treatment
- Podiatry referral if heel pain not improving with conservative measures
CPT Codes
- 99214 - Office visit, established patient, moderate complexity (30-39 minutes) - addressing multiple chronic conditions with medication adjustments
- 99215 - Office visit, established patient, high complexity (40-54 minutes) - if visit duration and complexity support this level
Modifiers: None required for standard office visit
Critical Pitfall: The 2-month follow-up interval is too long for uncontrolled hypertension. The 2025 AHA/ACC guidelines emphasize that frequency of follow-up depends on BP control status 2. Uncontrolled hypertension requires follow-up every 2-4 weeks until BP is at goal, then can extend to monthly or quarterly visits once controlled.